5F-Cumyl-PEGACLONE对心脏的影响
Nicole Esdar1,2, Evelyn Pawlik1, Simon B Eickhoff3
1Institute of Legal Medicine, University Hospital Düsseldorf, 40225, Düsseldorf, Germany.
International journal of legal medicine
|January 12, 2024
概括
像5F-Cumyl-PEGACLONE这样的合成大麻素会带来心血管疾病的风险. 这项研究发现,5F-Cumyl-PEGACLONE可以引起心脏不良影响,包括心律失常和潜在的心肌梗塞,特别是在更高度时.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 心血管研究研究心血管研究
背景情况:
- 合成大麻素越来越受欢迎,通常作为大麻的安全替代品销售.
- 制造商迅速创造新的合成大麻素来规避药物法,导致对其不良影响的知识不完全.
- 5F-Cumyl-PEGACLONE是一种在德国经常检测到的合成大麻素,关于其特定不良影响的数据有限.
研究的目的:
- 为了研究合成大麻素5F-Cumyl-PEGACLONE的潜在心血管不良影响.
- 为了评估5F-Cumyl-PEGACLONE对心脏功能的影响,使用一个隔离的透的老鼠心脏模型.
主要方法:
- 使用一个隔离的透的兰登多夫心脏模型与雄性Wistar老鼠心脏.
- 暴露于两种度的5F-Cumyl-PEGACLONE (50 ng/ml和100 ng/ml) 的心脏和对照组.
- 监测功能参数 (心率,心室压力,冠状动脉流量) 和记录心电图 (ECG).
主要成果:
- 多变量分析表明,与对照组相比,暴露在100ng/ml的5F-Cumyl-PEGACLONE中的心脏更频繁地被认为受到影响.
- 电脑电图评估显示了ST抑郁和QT延长的情况.
- 统计分析显示,QRS持续时间和最小左心室压力有一些显著的p值,尽管并非所有都通过了邦费罗尼校正.
结论:
- 研究结果表明,5F-Cumyl-PEGACLONE可以诱导严重的心脏不良反应,如心律失常和心肌梗塞.
- 这些风险可能会因与其他物质 (例如酒精) 或先前存在的心脏病的同时使用而加剧.
- 需要进一步的研究,以充分阐明5F-Cumyl-PEGACLONE的心脏毒性.
相关概念视频
Heart Failure Drugs: Inotropic Agents
591
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
591
Skeletal Muscle Relaxants: Adverse Effects
373
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
373
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
423
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
423
GPCRs Regulate Adenylyl Cylase Activity
5.6K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.6K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
744
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
744
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
806
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
806


